Address & contact
https://www.nccs.com.sg/Specialties
Reports that name this provider
- Alternative Cancer Treatment Availability in Singapore
- Country's premier public cancer institution. Piloting evidence-based integrative oncology program (not alternative cancer treatments). Acknowledges high CAM use among cancer patients but has no formal referral avenue to alternative wellness interventions due to regulatory constraints.
- Cancer Screening Quality in Singapore
- Provides national cancer screening guidelines and programmes. Routine subsidised screening not available to international patients.
- Cancer Treatment Cost Savings in Singapore
- Public-sector facility, operates Southeast Asia's largest radiotherapy department, houses Goh Cheng Liang Proton Therapy Centre which is the only public-sector proton facility in the region
- Chemotherapy & Immunotherapy Quality in Singapore
- JCI-accredited, ranked 6th in Asia-Pacific for oncology (Newsweek 2025), opened 24-storey oncology building in May 2023 with Goh Cheng Liang Proton Therapy Centre, leads 220+ Phase I-IV oncology clinical trials, 500+ completed trials
- Clinical Trial Access in Singapore
- Manages 220+ ongoing Phase I–IV trials, dedicated Experimental Cancer Therapeutics Unit, US FWA certified, conducts world's-first cancer vaccine trials, STRATUM trial (330-patient multinational study)
- Dental Surgery Quality in Singapore
- Participates in multidisciplinary head and neck tumour management with NDCS and SGH.
- Diagnostic Turnaround in Singapore
- Streamlined pathways for international oncology patients
- End-of-Life Counseling in Singapore
- Operates Department of Psychosocial Oncology; produces multilingual patient education videos in English, Chinese, Malay, and Tamil; provides bereavement support groups and individual counselling at no charge
- Genetic Testing Availability in Singapore
- Cancer Genetics Service headed by Associate Professor Joanne Ngeow; provides individualized cancer risk assessment and cascade testing for at-risk family members; offers BRCA1/2, Lynch syndrome, hereditary endocrine cancer, and neurofibromatosis testing
- Hospital Accreditation in Singapore
- JCI accredited since 2010. Only national cancer centre in the region with JCI recognition for healthcare standards, patient safety, and clinical governance.
- Hyperthermia Treatment in Singapore
- Public cancer institution. Operates Cytoreductive Surgery and HIPEC programme since April 2001 with over 335 documented procedures. Achieved 0% procedural mortality, 14.7% high-grade complication rate, 5-year overall survival of 44.8%. 12% of HIPEC patients are international self-referrals. SPRinT (Sarcoma, Peritoneal and Rare Tumours) programme offers clinical fellowships and runs Phase II clinical trials on prophylactic HIPEC for colorectal cancer and HIPEC for retroperitoneal sarcoma. Division of Radiation Oncology published peer-reviewed review of locoregional hyperthermia in 2023.
- Integrative Medicine Quality in Singapore
- Operates Traditional Medicine Information Service for oncologists and Psychosocial Oncology Department. No formal referral pathway to integrative oncology services exists currently due to regulatory constraints.
- Integrative Oncology Quality in Singapore
- Operates formal Integrative Oncology Clinic within Department of Medical Oncology providing acupuncture, mind-body therapies, lifestyle guidance, and coordinated TCM consultations. Department of Psychosocial Oncology provides clinical psychology, art therapy (ART CONNECT, ARTventure programs), medical social worker support, support groups including Sinar Harapan, mind-body therapy, and CARE Talks program. Operates rehabilitation gym in partnership with Singapore Cancer Society. Maintains Traditional Medicine Information Service (TMIS) for assessing herb-chemotherapy interactions. Conducts HERBAL trial (randomized controlled trial of Xiang Bei Yang Rong Tang for cancer-related fatigue) and operates >220 active clinical trials. Hosted Integrative Oncology Symposium in February 2025.
- Medical Technology in Singapore
- Goh Cheng Liang Proton Therapy Centre opened June 2023 with Hitachi proton therapy system; five treatment rooms with rotating gantries, pencil beam scanning; treats pediatric solid tumors, adult brain cancers, head and neck cancers, prostate cancers; launched UNITED 2.0 AI-powered multi-modal genomic cancer profiling project
- Medication Availability in Singapore
- Offers dedicated international patient programs
- Oncologic Surgery Quality in Singapore
- Ranked 6th in Asia Pacific oncology (Newsweek 2025). 130+ fellowship-trained surgeons across 13 subspecialties. New 24-story facility opened 2023. JCI-accredited since 2010 (only national cancer centre in region with JCI accreditation). Offers Surgery and Surgical Oncology Fellowship Programme for international surgeons. Goh Cheng Liang Proton Therapy Centre opened June 2023 with S$50 million endowment; over 300 patients treated by July 2024. Zero surgical mortality in 335 CRS/HIPEC cases through November 2018. Over 4,000 major liver surgeries and ~2,000 major pancreatic surgeries since 2000. Introduced CRS/HIPEC to Southeast Asia; co-founded Asian Peritoneal Surface Malignancy Group. Achieved 1,000th minimally invasive liver resection in 2023.
- Palliative Care Quality in Singapore
- Division of Supportive and Palliative Care employs advanced telehealth and nurse-led symptom monitoring tools for remote symptom management. Published 2024 trial on virtual monitoring efficacy in advanced cancer patients.
- Palliative Sedation Availability in Singapore
- Division of Supportive and Palliative Care developed the welfare-based model for palliative sedation; provides inpatient consultations and specialist outpatient services
- Pathology Quality in Singapore
- Operates IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) Molecular Tumour Board for lung cancer patient treatment assignment based on tumour molecular profiling; partnership with MGI Tech for comprehensive genomic profiling of Asian-prevalent cancers
- Radiation Therapy Quality in Singapore
- NCCS. Operates 17 linear accelerators, 2 MRI-Linac systems, and 4-gantry proton therapy center with Hitachi equipment. Goh Cheng Liang Proton Therapy Centre opened June 2023. JCI-accredited. Ranked 9th Asia-Pacific cancer hospitals (Newsweek 2023) and 68th globally (2024). 20+ radiation oncologists. Generates approximately 350 peer-reviewed publications annually, runs 220+ clinical trials.
- Second Opinion Services in Singapore
- Operates disease-specific multidisciplinary tumor boards and Molecular Tumour Board. Provides multidisciplinary tumour clinics where multiple specialties evaluate patients simultaneously, beneficial for international visitors with limited time.
- Specialist Credentials in Singapore
- Operates local HMDP fellowship programs
- Specialized Diagnostics in Singapore
- Operates robotic transperineal MRI-ultrasound fusion targeted prostate biopsy platform, described as current gold standard for prostate biopsy
- Stem Cell Legality in Singapore
- Treatment centre for approved cell therapy and CAR-T products
- Stem Cell Therapy Availability in Singapore
- Blood Cancer and Stem Cell Lab; cord blood expansion technologies research